Molecules 2017, 22, 109
7 of 14
solid (50.19 mg, 57%); m.p. 146.7–150.7 ◦C; 1H-NMR (500 MHz, CDCl3)
δ
6.04 (s, 2H), 1.72 (tt, J = 8.3,
5.0 Hz, 2H), 1.00–0.95 (m, 4H), 0.92–0.88 (m, 4H) ppm; 13C-NMR (125 MHz, CDCl3)
δ 179.5, 168.6,
111.1, 13.7, 7.8 ppm; IR (KBr): 3045, 3010, 2955, 1655, 1602, 1586, 1401, 1095, 1053, 858 cm−1; HRMS
(m/z) (APCI): calcd. for C11H13O2 177.0917 [M + H+]; found 177.0908.
2-Phenyl-6-propyl-4H-pyran-4-one (2k) [78]. The general procedure was used with 1-phenylocta-
1,4-diyn-3-one (98.04 mg, 0.5 mmol, 1 equiv.) and water (1 mL). The crude obtained was purified by
column chromatography (petroleum ether/ethyl acetate = 5:1 to 2:1) to afford the product as a brown
solid (83.50 mg, 78%); m.p. 49.8–51.5 ◦C; 1H-NMR (500 MHz, CDCl3)
δ
7.75 (dd, J = 7.7, 1.8 Hz, 1H),
7.51–7.46 (m, 1H), 6.72 (s, 1H), 6.19 (s, 1H), 2.60 (t, J = 7.5 Hz, 1H), 1.82–1.73 (m, 1H), 1.03 (t, J = 7.4 Hz,
1H) ppm; 13C-NMR (125 MHz, CDCl3)
δ 180.1, 168.8, 163.6, 131.5, 131.3, 129.0, 125.8, 114.0, 111.1, 35.6,
20.3, 13.5 ppm; IR (KBr): 3060, 2926, 1653, 1617, 1493, 1450, 1409, 1061, 937, 866, 772, 691 cm−1; HRMS
(m/z) (APCI): calcd. for C14H15O2 215.1074 [M + H+]; found 215.1065.
2-Phenyl-6-(p-tolyl)-4H-pyran-4-one (2l) [83]. The general procedure was used with 1-phenyl-5-(p-tolyl)
penta-1,4-diyn-3-one (112.04 mg, 0.5 mmol, 1 equiv.) and water (1 mL). The crude obtained was
purified by column chromatography (petroleum ether/ethyl acetate = 5:1 to 2:1) to afford the product
as a yellow solid (85.18 mg, 65%); m.p. 155.1–156.4 ◦C (lit: 150 ◦C); 1H-NMR (500 MHz, CDCl3)
δ
7.88–7.83 (m, 2H), 7.75 (d, J = 8.2 Hz, 2H), 7.54–7.51 (m, 3H), 7.32 (d, J = 8.1 Hz, 2H), 6.83–6.78 (m, 2H),
2.44 (s, 3H) ppm; 13C-NMR (125 MHz, CDCl3)
180.4, 163.6, 163.3, 142.0, 131.5, 131.4, 129.8, 129.1,
δ
128.6, 125.91, 125.86, 111.3, 110.7, 21.5 ppm; IR (KBr): 3064, 2922, 2854, 1646, 1606, 1448, 1413, 1387, 943,
816 cm−1; HRMS (m/z) (APCI): calcd. for C18H15O2 263.1074 [M + H+]; found 263.1061.
2-(4-Methoxyphenyl)-6-phenyl-4H-pyran-4-one (2m) [78]. The general procedure was used with
1-(4-methoxyphenyl)-5-phenylpenta-1,4-diyn-3-one (130.04 mg, 0.5 mmol, 1 equiv.) and water (1 mL).
The crude obtained was purified by column chromatography (petroleum ether/ethyl acetate = 5:1 to
2:1) to afford the product as a brown solid (97.33 mg, 70%); m.p. 161.3–162.2 ◦C (lit: 162 ◦C); 1H-NMR
(500 MHz, CDCl3)
δ 7.82 (dd, J = 6.6, 3.0 Hz, 2H), 7.78 (d, J = 8.9 Hz, 2H), 7.50 (dd, J = 5.0, 1.7 Hz, 3H),
7.00 (d, J = 8.9 Hz, 2H), 6.76 (d, J = 1.7 Hz, 1H), 6.70 (d, J = 1.7 Hz, 1H), 3.86 (s, 3H) ppm; 13C-NMR
(125 MHz, CDCl3)
δ 180.2, 163.3, 163.0, 162.2, 131.5, 131.2, 129.0, 127.5, 125.8, 123.6, 114.5, 111.1, 109.8,
55.4 ppm; IR (KBr): 3443, 3067, 2900, 2843, 1647, 1604, 1509, 1448, 1423, 1383, 1023, 832, 767, 684 cm−1
;
HRMS (m/z) (APCI): calcd. for C18H15O3 279.1014 [M + H+]; found 279.1013.
2-(4-Fluorophenyl)-6-phenyl-4H-pyran-4-one (2n). The general procedure was used with 1-(4-fluorophenyl)-
5-phenylpenta-1,4-diyn-3-one (124.03 mg, 0.5 mmol, 1 equiv.) and water (1 mL). The crude obtained
was purified by column chromatography (petroleum ether/ethyl acetate = 5:1 to 2:1) to afford the
◦
product as a yellow solid (77.16 mg, 58%); m.p. 145.5–150.6 C; 1H-NMR (500 MHz, CDCl3)
δ
7.89–7.82
(m, 4H), 7.56–7.51 (m, 3H), 7.22 (t, J = 8.5 Hz, 2H), 6.82 (d, J = 1.8 Hz, 1H), 6.77 (d, J = 1.8 Hz, 1H) ppm;
13C-NMR (125 MHz, CDCl3)
180.1, 165.6, 163.6, 163.4, 162.5, 131.5, 131.3, 129.2, 128.1 (d, J = 8.9 Hz),
δ
127.6, 125.9, 116.4 (d, J = 22.1 Hz), 111.3 (d, J = 24.2 Hz) ppm; IR (KBr): 3061, 2924, 1659, 1505, 1508,
1417, 1449, 1388, 1232, 1162 cm−1; HRMS (m/z) (APCI): calcd. for C17H12FO2 267.0823 [M + H+];
found 267.0813.
2-Cyclopropyl-6-phenyl-4H-pyran-4-one (2o) [84]. The general procedure was used with 1-cyclopropyl-
5-phenylpenta-1,4-diyn-3-one (97.04 mg, 0.5 mmol, 1 equiv.) and water (1 mL). The crude obtained was
purified by column chromatography (petroleum ether/ethyl acetate = 5:1 to 2:1) to afford the product
as a yellow solid (58.33 mg, 55%); m.p. 106.5–107.8 ◦C (lit: 106 ◦C); 1H-NMR (500 MHz, CDCl3)
δ
7.67
(dd, J = 7.9, 1.7 Hz, 2H), 7.50–7.45 (m, 3H), 6.69 (d, J = 2.1 Hz, 1H), 6.23 (d, J = 2.1 Hz, 1H), 1.90 (tt,
J = 7.9, 5.4 Hz, 1H), 1.12 (tt, J = 4.7, 2.5 Hz, 4H) ppm; 13C-NMR (125 MHz, CDCl3)
179.8, 169.5, 162.7,
δ
131.3, 131.2, 129.0, 125.6, 111.6, 111.0, 14.1, 8.5 ppm; IR (KBr): 3059, 2927, 1651, 1609, 1544, 1496, 1448,
1394, 1253, 1193, 1087, 931, 878, 766, 685 cm−1; HRMS (m/z) (APCI): calcd. for C14H13O2 213.0917
[M + H+]; found 213.0908.